http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150005160-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_799b6c8cb40ea97102dceda7bfe7b5c7 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-81 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
filingDate | 2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f961c54670db03fc1b89e09cdc523ba9 |
publicationDate | 2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20150005160-A |
titleOfInvention | Pharmaceutical composition for preventing and treating allergic disease comprising adenine or pharmaceutically acceptable salt thereof as an active ingredient |
abstract | More particularly, the present invention relates to a pharmaceutical composition for the prevention and treatment of allergic diseases comprising adenine or a salt thereof represented by the general formula (1) and a pharmaceutical composition for preventing and treating adenine or its A composition for inhibiting mast cell degranulation, inhibiting cytokine expression, and inhibiting icosanoid formation. The composition of the present invention can be used for prevention and treatment of allergic diseases by inhibiting degranulation, inhibition of transcription of the cytokine and production of icosanoids, which are allergenic mast cells. |
priorityDate | 2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 101.